Skip Navigation
Skip to contents

SICEM2024

Oral session

Oral session

Oral session 1 - Diabetes/Obesity/Lipid (clinical) 1 Day 2, Friday, April 12, 10:10-11:00 / Room 1 (1F)

Chairpersons: Eun Gyoung Hong (Hallym University, Korea), Min Kyong Moon (Seoul National University, Korea)

10:10-10:20 Hypothalamic obesity after surgery: prevalence and biomarkers Su Min Lee (Seoul National University, Korea)
10:20-10:30 Continuous glucose monitoring for glucose and weight management in prediabetes and type 2 diabetes: a prospective community-based (workplace) cohort study Ji Hee Ko (Sungkyunkwan University, Korea)
10:30-10:40 Shared genetic etiology between insomnia and metabolic traits: a genome-wide cross trait analysis Chun Hei Wu (The University of Hong Kong, Hong Kong )
10:40-10:50 DNA methylation profiling of metabolic, inflammatory, and stress response genes in South African women with obesity: implications for mechanisms, biomarkers, and early interventions for type 2 diabetes Ayesha Shaik (Stellenbosch University, South Africa)
10:50-11:00 Development of biological ages through unsupervised and self-supervised deep learning models based on morbidity and mortality Jae Hyun Bae (Korea University, Korea)
Oral session 2 - Thyroid Day 2, Friday, April 12, 10:10-11:00 / Room 2 (1F)

Chairpersons: Dong-Jun Lim (The Catholic University of Korea, Korea), Dong Yeob Shin (Yonsei University, Korea)

10:10-10:20 Spatial distribution of immune cells in advanced thyroid cancers using multiplexed fluorescent immunohistochemistry Chae A Kim (University of Ulsan, Korea)
10:20-10:30 High-dose radioactive iodine therapy is assoicated with PPM1D-mutant clonal hematopoiesis Jaeryuk Kim (University of Ulsan, Korea)
10:30-10:40 Association of BRAF mutation status with tumor volume doubling time in active surveillance of papillary thyroid microcarcinoma Jinyoung Kim (The Catholic University of Korea , Korea)
10:40-10:50 Performance validation of machine learning-assisted system for predicting clinical activity score in thyroid eye disease: a clinical trial for approval by the Ministry of Food and Drug Safety of the Republic of Korea Jae Hoon Moon (Seoul National University, Korea)
10:50-11:00 Cost-effectiveness analysis of thyroidectomy compared to antithyroid drug and radioactive iodine for the treatment of relapsed Graves' disease Xiaodong Liu (The University of Hong Kong, Hong Kong)
Oral session 3 - Bone/Muscle Day 2, Friday, April 12, 10:10-11:00 / Room 3 (B2)

Chairpersons: Seong Bin Hong (Inha University, Korea), Sang Wan Kim (Seoul National University, Korea)

10:10-10:20 Early and multiple zoledronate treatment prevents rebound bone loss following withdrawal of RANKL inhibition Albert Kim (Garvan Institute of Medical Research, Australia)
10:20-10:30 Age-related decrease of type IIx fibers in the vastus lateralis of patients with hip fracture Minchul Song (Chungnam National University, Korea)
10:30-10:40 Efficacy and safety of weekly liquid alendronate sodium trihydrate in Korean postmenopausal women with osteoporosis: a 12-month, multi-center, randomized trial Seong Hee Ahn (Inha University, Korea)
10:40-10:50 Dimeric [Cys25]PTH(1-34) induces differential transcriptional responses versus monomeric PTH(1-34) Minsoo Noh (Gachon University, Korea)
10:50-11:00 Relationship of CCL2 to muscle-related parameters in mouse models of sarcopenia and human sarcopenia Mi Kyung Kwak (Hallym University, Korea)
Oral session 4 - Pituitary/Adrenal/Gonad Day 2, Friday, April 12, 10:10-11:00 / Room 4 (B2)

Chairpersons: Jae Hyeon Kim (Sungkyunkwan University, Korea), Sang Ouk Chin (Kyung Hee University, Korea)

10:10-10:20 Epidemiology of multiple endocrine neoplasia type 1 in South Korea: a nationwide cohort study Kyoung Jin Kim (Korea University, Korea)
10:20-10:30 The role of corrected serum potassium and renin in predicting lateralized results of adrenal vein sampling Sen-Yu Liu (National Taiwan University, Taiwan)
10:30-10:40 Aging matters: addressing the challenges in screening of primary aldosteronism in elderly individuals Zhengwei Chen (National Taiwan University, Taiwan)
10:40-10:50 Association of plasma aldosterone concentration after captopril suppression test with left ventricular remodeling and diastolic dysfunction in primary aldosteronism Cheng-Hsuan Tsai (National Taiwan University, Taiwan)
10:50-11:00 Machine learning-based, one-step diagnosis of adrenal diseases Seung Shin Park (Seoul National University, Korea)
Oral session 5 - Diabetes/Obesity/Lipid (basic) Day 2, Friday, April 12, 10:10-11:00 / Room 5 (4F)

Chairpersons: Soo Lim (Seoul National University, Korea), Byung-Chul Oh (Gachon University, Korea)

10:10-10:20 Rescue of diabetic gastroparesis through neuronal modulation and its monitoring via breath volatile organic compounds analysis in mouse models Evonne Kim (Seoul National University, Korea)
10:20-10:30 Orexin increases food intake via hypothalamic POMC neurons Jeewon Choi (KAIST, Korea)
10:30-10:40 PHD3 is an attractive cancer therapeutics target that is dual-localized in cytosol and mitochondria. Jaelim Sim (Korea University, Korea)
10:40-10:50 Targeting HIF1A enhances exercise benefits when challenged with high-fat diet Josephine Yu (University of Sydney, Australia)
10:50-11:00 S1PR2 inhibition modulates microglial activation via Akt-p53-TIGAR pathway in diabetic rats to improve cognition. Dharmendra Kumar Khatri (NIPER-Hyderabad, India)
Oral session 6 - Diabetes/Obesity/Lipid (clinical) 2 Day 2, Friday, April 12, 16:50-17:40 / Room 1 (1F)

Chairpersons: Hye Seung Jung (Seoul National University, Korea), Mi-Kyung Kim (Inje University, Korea)

16:50-17:00 Investigating the impact of probiotic intervention on inflammatory biomarkers in metabolic syndrome Nadyatul Husna (Universitas Andalas, Indonesia )
17:00-17:10 Whole exome sequencing analysis of patients with type 2 diabetes who relied on sulfonylureas for glycemic control Jinsun Jang (Seoul National University, Korea )
17:10-17:20 Fatty liver index dynamics and hepatocellular carcinoma risk in type 2 diabetes Min Gu Kang (Jeonbuk National University, Korea )
17:20-17:30 Efficacy and safety of maximal 15 mg dose Tirzepatide, a novel dual GIP/GLP-1 receptor agonist, compared to other doses in type 2 diabetes management: a systematic review and meta-analysis of randomized controlled trials Muhammad Bilal Saifulhaq (Saiful Anwar Regional Hospital, Indonesia)
17:30-17:40 Insulin resistance accelerates cognitive decline in midlife women Lin Liu (The University of Hong Kong, Hong Kong)
Korean Endocrine Society
101-2503, Lotte Castle President, 109, Mapo-daero, Mapo-gu, Seoul 04146, Republic of Korea
T. +82-2-714-2428  |  E. endo@endocrinology.or.kr  |  W. www.endocrinology.or.kr
Business Registration Number: 106-82-31133  |  Name of Representative : Yoon-Sok (Martin) Chung
SICEM 2025 Secretariat (INTO-ON)
4F, A-Block, Richensia, 341, Baekbeom-ro, Yongsan-gu, Seoul 04315, Republic of Korea
T. +82-2-2039-7804  |  E. endo@into-on.com  |   W. www.into-on.com

Copyright ⓒ The Korean Endocrine Society. All rights Reserved